Standout Papers

Addition of cetuximab to chemotherapy as first-line treatment for KRAS wild-type metastatic colore... 2012 2026 2016 2021 431
  1. Addition of cetuximab to chemotherapy as first-line treatment for KRAS wild-type metastatic colorectal cancer: Pooled analysis of the CRYSTAL and OPUS randomised clinical trials (2012)
    Carsten Bokemeyer, Eric Van Cutsem et al. European Journal of Cancer

Immediate Impact

1 from Science/Nature 61 standout
Sub-graph 1 of 21

Citing Papers

Polymeric Nanoparticles for Drug Delivery
2024 Standout
The Rise of Boron-Containing Compounds: Advancements in Synthesis, Medicinal Chemistry, and Emerging Pharmacology
2024 Standout
3 intermediate papers

Works of S. Heeger being referenced

Phase I trial of methotrexate-albumin in a weekly intravenous bolus regimen in cancer patients. Phase I Study Group of the Association for Medical Oncology of the German Cancer Society.
1999

Author Peers

Author Last Decade Papers Cites
S. Heeger 877 391 216 237 32 1.2k
Claudia Maggi 855 354 153 325 35 1.3k
Marlies Michl 683 373 238 145 46 1.1k
Annette Frost 736 486 205 226 29 1.3k
José María Viéitez 1064 549 285 192 52 1.4k
Julian Walter Holch 795 339 200 345 48 1.1k
V. Izraël 928 321 220 291 37 1.4k
Silvia Mezi 983 398 215 283 50 1.3k
Cécile Charpy 640 250 273 137 29 1.1k
Oliver Rosen 679 399 135 217 18 1.2k
Chiara Pierantoni 793 362 148 150 40 1.2k

All Works

Loading papers...

Rankless by CCL
2026